Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 26, 2016

View Archived Issues

Phase I safety and pharmacokinetic results for BHV-0223

Orphan drug designation granted for RE-024 in Europe for the treatment of PKAN

European orphan drug designation for EYS-606 in refractory noninfectious uveitis

Data presented for phase II RADIANCE study of ozanimod

FDA approves Pfizer's Xeljanz XR extended-release tablets

Initiation of phase II study of fostamatinib in autoimmune hemolytic anemia

Alkermes announces positive topline results for 2-month dosing option of Aristada

FDA grants orphan drug designation to ZYN-002 for Fragile X syndrome

Roche discloses BACE1 inhibitors

Narcan now available in U.S. for the treatment of opioid overdose

Redx Pharma patents antibacterial compounds

Pfizer patent reports JAK inhibitors

University of British Columbia introduces pyruvate kinase inhibitors

PI3K and mTOR inhibitors described in Shandong Huiruidi Biotechnology patent

Interim phase III analysis shows improved pain scores in ER patients treated with ARX-04

Seattle Genetics initiates phase I trial of SGN-CD19B

NephroGenex pauses Pyridorin clinical program, restructures

Novartis seeks Japanese approval of artemether/lumefantrine

Phase I safety and PK data presented for BMS-986120

Teva to begin strategic corporate identity program to build global brand

UCB terminates epratuzumab agreement with Immunomedics

Takeda's combination packs for H. pylori eradication approved in Japan

EMA grants orphan drug designation to TNT-009 for autoimmune hemolytic anemia

Peregrine stops phase III bavituximab study in NSCLC following interim analysis

FDA places pivotal study of CR-845 for postoperative pain on protocol clinical hold

OSE Pharma and Effimune to merge

Luminex to validate GenArraytion's Zika virus assay

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...